Back
Phathom Pharmaceuticals, Inc. 10K Form
Sell
28
PHAT
Phathom Pharmaceuticals, Inc.
Last Price:
$11.16
Seasonality Move:
-6.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAT News And Ratings
See the #1 stock for the next 7 days that we like better than PHAT
PHAT Financial Statistics
Sales & Book Value
| Annual Sales: | $175.1M |
|---|---|
| Cash Flow: | $-5.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-6.14 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.05150 |
|---|---|
| Net Income (TTM): | $-221.2M |
| Gross Margin: | $152.5M |
| Return on Equity: | 0% |
| Return on Assets: | -77.74% |
Phathom Pharmaceuticals, Inc. Earnings Forecast
Key Phathom Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for PHAT is 87.09%.
-
The Selling, General & Administrative Expenses for PHAT have been equal to 159.74% of Gross Profit Margin.
-
The Research & Development expenses have been 18.72% of Revenue.
-
The Net Earning history of PHAT is -126.35% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Phathom Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PHAT |
| CUSIP: | 71722W |
| Website: | phathompharma.com |
Debt
| Debt-to-Equity Ratio: | -1.34 |
|---|---|
| Current Ratio: | 1.73 |
| Quick Ratio: | 1.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 7.11 |
PHAT Technical Analysis vs Fundamental Analysis
Sell
28
Phathom Pharmaceuticals, Inc. (PHAT)
is a Sell
Is Phathom Pharmaceuticals, Inc. a Buy or a Sell?
-
Phathom Pharmaceuticals, Inc. stock is rated a SellThe current Phathom Pharmaceuticals, Inc. [PHAT] share price is $11.46. The Score for PHAT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.